Life Science Executive Awards
Monday 16 November 2026City Central at the HAC, London, UKDeal of the Year (<€500m)
This award recognises the teams and organisations who have executed a truly transformational and high value creating deal for both the company and the wider industry. The deal could be a licensing agreement, co-development or a creative alliance or partnership that unlocks significant value.
Congratulations to this year's finalist roster.
There will be 1st (Gold), 2nd (Silver), and 3rd (Bronze) place announcements in each category, with 1st place exclusively awarded the bespoke trophy.
Criteria & Judging
Qualifying criteria:
- Total deal size (not milestone payments) must be less than €500m
- The lead company must be a European Life Science company
- Open to private or public companies WITH pharma, commercial leaders or big tech
- Deal can be either a licensing deal involving a particular drug, project or group of drugs/projects
- A license, partnership or alliance between companies NOT M&A
- Deal to have completed in the period between 1 September 2025 and 1 August 2026
